Skip to main content
. 2020 Jan 7;12(1):51. doi: 10.3390/pharmaceutics12010051

Figure 8.

Figure 8

XRPD patterns of theophylline granules (20%) based on Cloisite–Eudragit RS nanocomposites and individual components. (A) Cloisite Na–Eudragit RS nanocomposites at different clay to polymer ratios, (B) Cloisite 20-Eudragit RS nanocomposites at different clay to polymer ratios.